Metformin Clinical Trials
59 actively recruiting trials across 16 locations
Also known as: Fortamet, Glucient, Glucophage, Glucophage extended release (XR), Glucophage, Glucophage XR, Fortamet, and Glumetza +10 more
Pipeline
Top Sponsors
- University of California, San Francisco3
- Mostafa Bahaa3
- The University of Texas Health Science Center at San Antonio2
- Karolinska Institutet2
- Assistance Publique - Hôpitaux de Paris2
Indications
- Cancer24
- Diabetes22
- Metformin5
- Heart Disease4
- Arthritis4
Other39 trials
San Francisco, California2 trials
UCSF Medical Center
University of California, San Francisco
Chicago, Illinois2 trials
University of Illinois at Chicago
Pittsburgh, Pennsylvania2 trials
Univ of Pittsburgh Medical Center Hillman Cancer Center
UPMC Hillman Cancer Center
San Antonio, Texas2 trials
The University of Texas Health Science Center at San Antonio
University of Texas Health Science Center at San Antonio
Tuscaloosa, Alabama1 trial
University of Alabama
Little Rock, Arkansas1 trial
University of Arkansas for Medical Sciences
Duarte, California1 trial
Oakland, California1 trial
UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic
Aurora, Colorado1 trial
Colorado Research Center
Atlanta, Georgia1 trial
Emory University
Indianapolis, Indiana1 trial
Indiana University School of Medicine
Louisville, Kentucky1 trial
James Graham Brown Cancer Center-University of Louisville
Boston, Massachusetts1 trial
Massachusetts General Hospital Cancer Center
Detroit, Michigan1 trial
Karmanos Cancer Institute
Rochester, Minnesota1 trial
Buffalo, New York1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.